Assembly Biosciences Profit Margin

Assembly Biosciences (ASMB) currently reports a profit margin of -0.1% as of June 2026. That compares with -274.36% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Assembly Biosciences's profit margin history and peer comparisons.

Assembly Biosciences's profit margin increased from -274.36% to -0.1% — a 100.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Assembly Biosciences's profit margin of -0.1% is lower than the Healthcare sector average of 10.58%. That is roughly 100.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Assembly Biosciences's current -0.1% should be judged against Healthcare norms (sector average: 10.58%) and against ASMB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -0.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Assembly Biosciences, and consider following ASMB for alerts when major investors trade the stock.